Literature DB >> 9631404

Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study.

J Phoenix1, P Hopkins, C Bartram, R J Beynon, R C Quinlivan, R H Edwards.   

Abstract

A patient-blind study into the effect of a 10-week cessation of long-term vitamin B6 supplementation on B6 status and performance in McArdle's disease is reported. Muscle performance was assessed both subjectively and objectively by an ischaemic fatiguing protocol of the adductor pollicis muscle. Nine weeks after withdrawal of supplementation, vitamin B6 status had changed from adequacy to inadequacy and the force loss during the ischaemic fatiguing protocol had increased at all frequencies studied. The patient reported decreased exercise tolerance after 7 weeks and by the tenth week was experiencing an increase in muscle cramps. Vitamin B6 status and muscle performance may be linked in McArdle's disease and there is potential for enhancement of performance by B6 supplementation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631404     DOI: 10.1016/s0960-8966(98)00004-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

Review 1.  Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).

Authors:  Rosaline Quinlivan; Andrea Martinuzzi; Benedikt Schoser
Journal:  Cochrane Database Syst Rev       Date:  2014-11-12

Review 2.  Molecular genetics of McArdle's disease.

Authors:  G Nogales-Gadea; J Arenas; A L Andreu
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 3.  Pharmacological and nutritional treatment trials in McArdle disease.

Authors:  R M Quinlivan; R J Beynon
Journal:  Acta Myol       Date:  2007-07

Review 4.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

5.  The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Astrid Brull; Noemi de Luna; Alejandro Lucia; Tomàs Pinós
Journal:  J Inherit Metab Dis       Date:  2014-07-23       Impact factor: 4.982

6.  Novel Asp511Thr mutation in McArdle disease with acute kidney injury caused by rhabdomyolysis.

Authors:  Ayaka Satoh; Shuma Hirashio; Takahiro Arima; Yumi Yamada; Taisuke Irifuku; Haruka Ishibashi; Atsuko Motoda; Yoshimasa Sueda; Takao Masaki
Journal:  CEN Case Rep       Date:  2019-03-21

7.  [Metabolic and mitochondrial myopathies].

Authors:  M Vorgerd; M Deschauer
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

Review 8.  Adeno-associated virus-mediated gene therapy for metabolic myopathy.

Authors:  Cathryn S Mah; Meghan S Soustek; A Gary Todd; Angela McCall; Barbara K Smith; Manuela Corti; Darin J Falk; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2013-11       Impact factor: 5.695

9.  Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits.

Authors:  Alfredo Santalla; Diego Munguía-Izquierdo; Lidia Brea-Alejo; Itziar Pagola-Aldazábal; Jorge Díez-Bermejo; Steven J Fleck; Ignacio Ara; Alejandro Lucia
Journal:  Front Aging Neurosci       Date:  2014-12-11       Impact factor: 5.750

10.  Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.

Authors:  Noemí de Luna; Astrid Brull; Josep Maria Guiu; Alejandro Lucia; Miguel Angel Martin; Joaquin Arenas; Ramon Martí; Antoni L Andreu; Tomàs Pinós
Journal:  Dis Model Mech       Date:  2015-03-11       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.